Ribo submits Phase 2 trial application for RBD1119 to European regulator

US FDA extends review timeline for AstraZeneca's camizestrant application

Circio and AaviGen partner to develop next-generation gene therapies for heart disease

CordenPharma acquires AmbioPharm, expanding peptide API capacity

OncoZenge secures European approval for Phase III BEAM-Pain trial of BupiZenge

AstraZeneca's Enhertu recommended for EU approval in HER2-positive solid tumours

Lundbeck's Vyepti (eptinezumab) receives South Korean approval for preventive treatment of migraine

Eli Lilly reports positive Phase 1b results for VERVE-102

Pierre Fabre Laboratories' BRAFTOVI (encorafenib) combination receives CHMP positive opinion in BRAFV600E-mutant mCRC

Menarini Group to present new elacestrant and tagraxofusp data at ASCO 2026 Annual Meeting

Hansa Biopharma's ConfIdeS Phase 3 trial abstract selected for ATC 2026

Dicot Pharma submits FDA application for LIB-01 phase 2b study

European Commission approves Pharming's Joenja for APDS treatment in the EU

Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514

AbbVie's MAVIRET receives positive opinion from European regulator